Related Experiment Video
Updated: May 28, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Prefrontal Structural Asymmetry Mediates Body Mass Index and Treatment Response in Major Depressive Disorder
Kaini Qiao1, Zhenxiang Zang1, Yun Wang1
1National Clinical Research Center for Mental Disorders & National Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China, ccmu.edu.cn.
Background:
Elevated body mass index (BMI) predicts poor treatment response in major depressive disorder (MDD), yet the neurobiological mechanisms underlying this association remain poorly understood. Cortical thickness asymmetry has been proposed as a structural correlate of affective regulation and may represent a pathway through which metabolic factors influence treatment outcomes. We investigated whether BMI-related alterations in prefrontal cortical asymmetry mediate antidepressant treatment resistance in MDD.
Methods:
We analyzed baseline structural MRI (sMRI) and 12-week clinical outcome data from 312 adults with MDD across a discovery cohort (n = 107) and an independent replication cohort (n = 205). Treatment response was operationalized as absolute reduction in Hamilton depression rating scale (HAMD-17) scores. Cortical thickness asymmetry indices were derived from regional parcellations. Associations between BMI and asymmetry were examined using linear regression models; mediation analyses tested whether BMI-related asymmetry statistically mediates the link between higher BMI and reduced treatment response. Sex-stratified analyses were conducted to identify divergent pathways.
Results:
Across both cohorts, higher BMI was consistently associated with greater leftward cortical thickness asymmetry in the prefrontal cortex (PFC). This structural asymmetry significantly mediated the relationship between BMI and poorer treatment response. Sex-stratified analyses revealed additional female-specific mediation through prefrontal opercular regions, with no corresponding effect in males. Transcriptomic annotation of implicated regions identified enrichment for genes involved in metabolic and cytoplasmic signaling pathways.
Conclusions:
BMI-associated leftward prefrontal asymmetry statistically mediates antidepressant resistance in MDD via both a sex-shared structural pathway and a female-specific opercular circuit. These findings suggest that metabolic factors may influence treatment outcomes partly through hemispheric structural imbalance in prefrontal regions and position cortical thickness asymmetry as a candidate neuroimaging biomarker for patient stratification in precision psychiatry.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Depressive Disorders: MDD and Dysthymia
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depression: Overview
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Bipolar Disorder

